Noxious colorectal distention induced-c-Fos protein in limbic brain structures in the rat
As of November 2023, it was added to the FDA drug shortage list
They include nausea, vomiting, diarrhea, stomach pain, and constipation
GLP-1 Analogues Market Regional Analysis North America Holds the Largest Share in the GLP-1 Analogues Market North America dominates the GLP-1 analogues market with an estimated market share of over 76.05%, primarily driven by high obesity and diabetes prevalence, strong healthcare infrastructure, and early adoption of innovative therapies U.S
Sales: $7.4 Billion Headcount: 4,000 Pharma Revenues: $7,390 (14%) Total Revenues: $7,949 (13%) Net Income: $2,890 (10%) R&D Budget: $1,073 (14%) Top-Selling Drugs in 2010 Account for 99% of total pharma sales, same as in 2009